Sign inJoin waitlistJoin the waitlist

Sally Arai

Hematology · Stanford Health Care

Credentials: · · · ·

History

Johns Hopkins Hospital
Until 1999
Mount Sinai Medical Center
Until 1998
Strong Memorial Hospital
Until 1995
Strong Memorial Hospital
Until 1993
Dartmouth Geisel School of Medicine
1991

Research

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group…
Biology of Blood and Marrow Transplantation · 2015 · 2,533 citations
CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial
Nature Medicine · 2021 · 534 citations
Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research
Biology of Blood and Marrow Transplantation · 2015 · First of 63 authors · 370 citations

David Miklos
53 papers
Laura Johnston
47 papers
Robert Lowsky
45 papers
Robert Negrin
40 papers
Wen-Kai Weng
40 papers
Judith Shizuru
39 papers
Andrew Rezvani
33 papers
Lori Muffly
33 papers
Stephanie Lee
33 papers
JP
Joseph Pidala
30 papers · 2 as a fellow
Everett Meyer
29 papers
Surbhi Sidana
28 papers

Grants

GVHD and Relapse:Ex-Vivo Expanded Allogeneic Therapy
National Institute of Allergy and Infectious Diseases · K23
Contact PI · $655K · Stanford University
2003–2008

Clinical trials

High-Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma
Principal investigator · Completed · Phase 2
Stanford University
2006–2010
A Phase 2 Trial of Rituximab and Corticosteroid Therapy for Newly Diagnosed Chronic Graft Versus Host Disease
Principal investigator · Completed
Stanford University
2006–2014
Post-transplant Autologous Cytokine-induced Killer (CIK) Cells for Treatment of High Risk Hematologic Malignancies
Principal investigator · Completed · Phase 1
Sally Arai
2006–2011
Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease
Principal investigator · Completed · Phase 2
Stanford University
2001–2010